Skip to content

13F-HR filed by QVT Financial LP

QVT Financial LP filed this 13F-HR for the quarter ended 2013-06-30, filed 2013-08-14, with 63 holding rows worth $1,486,927,000.

Accession
0000950123-13-006878
Filed
2013-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2013

A holdings report, 63 entries on the cover page, a total value of $1,486,927,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,486,927,000 with VALUE read as thousands by filing date, 13F file number 028-11172. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
VIVUS INC928551100COM8,346,697$105,001,000thousands by filing date
SALESFORCE COM INC79466LAB0BOND52,500,000$95,303,000thousands by filing dateprincipal
ACHILLION PHARMACEUTICALS IN00448Q201COM10,967,853$86,889,000thousands by filing date
TENET HEALTHCARE CORP COM NEW88033G407Stock1,664,493$76,733,000thousands by filing date
ILLUMINA INC452327AB5NOTE 0.625% 2/116,135,000$55,319,000thousands by filing dateprincipal
CAPITAL ONE FINL CORP14040H105COM778,235$48,881,000thousands by filing date
E TRADE FINANCIAL CORP269246401COM NEW3,763,493$47,646,000thousands by filing date
WESCO INTERNATIONAL INC95082PAH8CNV19,000,000$47,053,000thousands by filing dateprincipal
SBA COMMUNICATIONS CORP78388JAM8CORPORATE OBLIG17,500,000$43,219,000thousands by filing dateprincipal
CLOVIS ONCOLOGY INC189464100COM617,678$41,372,000thousands by filing date
PHARMACYCLICS INC716933106COM519,982$41,323,000thousands by filing date
CREE INC225447101COM600,000$38,298,000thousands by filing dateput
HALOZYME THERAPEUTICS INC COM40637H109Stock4,601,500$36,582,000thousands by filing date
SCORPIO TANKERS INCY7542C106COMMON STOCK-FO3,778,084$33,927,000thousands by filing date
ROWAN COMPANIES PLCG7665A101SHS CL A975,954$33,251,000thousands by filing date
JPMorgan Chase & Co46625H100COM621,460$32,807,000thousands by filing date
DST SYS INC DEL233326107COM473,783$30,952,000thousands by filing date
GREEN DOT CORP CLASS A39304D102CL A1,494,181$29,809,000thousands by filing date
INTERMUNE INC45884X103COM2,861,868$27,531,000thousands by filing date
MEDIVATION INC58501N101COM547,628$26,943,000thousands by filing date
Lincoln National Corporat524901105COM842,168$26,116,000thousands by filing date
NATIONAL RETAIL PPTYS INC NOTE 5.125% 6/1637417AC0Common19,000,000$25,867,000thousands by filing dateprincipal
MEDIVATION INC58501NAA9NOTE19,750,000$25,242,000thousands by filing dateprincipal
YPF SOCIEDAD ANONIMA984245100SPON ADR CL D1,706,509$25,188,000thousands by filing date
OCWEN FINL CORP675746309COM NEW610,200$25,152,000thousands by filing dateput
Tesla Motors, Inc88160R101COM225,000$24,156,000thousands by filing date
TRANSOCEAN LTD REGISTERED SHSH8817H100Stock496,343$23,800,000thousands by filing date
OPTIMER PHARMACEUTICALS INC68401H104COM1,629,800$23,583,000thousands by filing date
REPROS THERAPEUTICS INC76028H209COM1,240,588$22,091,000thousands by filing date
Citigroup Inc.172967424COM459,873$22,060,000thousands by filing date
BRF SA10552T107SPONSORED ADR997,220$21,650,000thousands by filing date
INFINITY PHARMACEUTICALS INC45665G303COM1,326,610$21,480,000thousands by filing date
CBRE GROUP INC CL A12504L109Stock831,320$19,420,000thousands by filing date
INTERMUNE INC45884XAF0NOTE 2.500%12/118,000,000$19,331,000thousands by filing dateprincipal
Wells Fargo & Company949746101COM419,292$17,304,000thousands by filing date
ARRAY BIOPHARMA INC COM04269X105Stock3,437,293$15,605,000thousands by filing date
REPROS THERAPEUTICS INC76028H118*W EXP 02/08/201874,635$15,566,000thousands by filing date
HCA Healthcare Inc40412C101COM407,118$14,681,000thousands by filing date
Synta Pharmaceuticals Corp.87162T206COM2,430,985$12,131,000thousands by filing date
REPROS THERAPEUTICS INC76028H126*W EXP 02/08/201708,969$10,859,000thousands by filing date
CST BRANDS INC12646R105COM302,500$9,320,000thousands by filing date
Peregrine Semiconductor71366R703COM800,000$8,728,000thousands by filing date
ARRAY BIOPHARMA INC04269XAA3NOTE 3.000% 6/09,000,000$8,563,000thousands by filing dateprincipal
UNIVERSAL DISPLAY CORP91347P105COM300,000$8,433,000thousands by filing dateput
ANACOR PHARMACEUTICALS INC032420101COM1,358,303$7,593,000thousands by filing date
CHINA ZENIX AUTO INTL LTD16951E104ADS3,047,200$7,070,000thousands by filing date
KERYX BIOPHARMACEUTICALS492515101COMMON STOCK912,000$6,813,000thousands by filing date
STEMLINE THERAPEUTICS INC85858C107COM220,000$5,245,000thousands by filing date
CMS ENERGY CORP125896BD1CNV2,500,000$4,978,000thousands by filing dateprincipal
ONCOGENEX PHARMACEUTICALS IN68230A106COM400,000$3,920,000thousands by filing date
EPIZYME INC29428V104COM125,000$3,516,000thousands by filing date
VERASTEM INC92337C104COM271,101$3,397,000thousands by filing date
PACIFIC DRILLING SA LUXEMBOUL7257P106REG SHS329,815$3,226,000thousands by filing date
ASBURY AUTOMOTIVE GROUP INC COM043436104Stock70,074$2,810,000thousands by filing date
QLT INC746927102COMMON STOCK625,000$2,744,000thousands by filing date
DYAX CORP26746E103COM770,683$2,667,000thousands by filing date
THE9 LTD88337K104ADR752,963$2,454,000thousands by filing date
PALATIN TECHNOLOGIES INC696077403COM PAR $ .013,873,000$2,050,000thousands by filing date
HOME LN SERVICING SOLUTIONSG6648D109ORD SHS77,900$1,867,000thousands by filing dateput
TRANZYME INC89413J102COM1,145,655$538,000thousands by filing date
Walter Energy Inc93317Q105COM49,300$513,000thousands by filing date
IDENIX PHARMACEUTICALS INC45166R204COM100,000$361,000thousands by filing date
ARMOUR RESIDENTIAL REIT INC042315119WARRANT1,651,796$0thousands by filing dateValue filed as zero, left out of ratios.

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000950123-13-006878this filing2013-08-14acceptance time not in the bulk data set